ANALYSIS: Tax reforms would boost R&D by $20bn, add 600k+ jobs
This article was originally published in Scrip
Executive Summary
A new analysis from Ernst & Young has provided American biotechs and other small research-intensive businesses the evidence they need to back up their pleas to Congress to change certain tax rules for "pre-revenue" innovators, with the report showing adoption of three proposals could increase total investment in those companies by $20.6bn and result in the creation of about 623,000 new jobs.